- 1、本文档共59页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
cGMP21CFR210211中英对照
21 Code of Federal Regulations Parts
210 and 211
Part 210
- CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL
PART 211 ?
- CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS
210部分—人用及兽用药品的生产、加工、包装或贮存的CGMP(概述)
211部分—制剂药品的CGMP
Part 210 - CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL
210.1 Status of current good manufacturing practice regulations.
210.2 Applicability of current good manufacturing practice regulations.
210.3 Definitions.
AUTHORITY: Secs. 201, 501, 502, 505, 506, 507, 512, 701, 704 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 351, 352, 355, 356, 357, 360b, 371, 374).
SOURCE: 43 FR 45076, Sept. 29, 1978, unless otherwise noted.
§ 210.1 Status of current good manufacturing practice regulations.
(a) The regulations set forth in this part and in Parts 211 through 226 of this chapter contain the minimum current good manufacturing practice for methods to be used in, and the facilities or controls to be used for, the manufacture, processing, packing, or holding of a drug to assure that such drug meets the requirements of the act as to safety, and has the identity and strength and meets the quality and purity characteristics that it purports or is represented to possess.
(b) The failure to comply with any regulation set forth in this part and in Parts 211 through 226 of this chapter in the manufacture, processing, packing, or holding of a drug shall render such drug to be adulterated under section 501(a)(2)(B) of the act and such drug, as well as the person who is responsible for the failure to comply, shall be subject to regulatory action.
§ 210.2 Applicability of current good manufacturing practice regulations.
(a) The regulations in this part and in Parts 211 through 226 of this chapter as they may pertain to a drug and in Parts 600 through 680 of this chapter as they may pertain to a biological product for human us
您可能关注的文档
- 北师大版高中英语模块六知识点训练和模块测试试卷及答案.doc
- FDA发布咀嚼片关键质量属性指导原则.docx
- 脂肪干细胞成脂分化的研究进展_陈犹白_陈聪慧_QixuZhang_韩岩.pdf
- 首都师范大学翻译硕士专业考研英语翻译基础考试重点及答题技巧汇总.pdf
- 2011年12月六级必考词汇.doc
- 母系遗传药物性耳聋与线粒体ND5T12338C突变的关系_褚雪莲.pdf
- 对比欧盟、日本、我国指导原则,探讨中药新药治疗冠心病心绞痛(稳定型)Ⅱ期临床试验设计关键因素.pdf
- 古文献痿病方药关联规则分析_杨春梅.pdf
- 精神分裂症患者服药依从性的评价方法(综述).pdf
- 2015年高考全国I卷答案.docx
- 分析let s单元56ago2卷纸zheng unit56.pdf
- 塑胶材料其它分类原料pa9t 12.pdf
- md16x16数字媒体切换器设备.pdf
- 者参考项目发起人学科类型单位序列承包商修订页代码顺序典型.pdf
- 届世界天然气大会阿姆斯特丹2006add10288.pdf
- 期测试记录表每周weekly g1g6 journeys tests level 6 lesson26.pdf
- modernize-whitepaper现代化您应用程序白皮书.pdf
- anybackup产品典型案例分析.pdf
- 约克金融工程课程tfeslide32.pdf
- 广州市妇女儿童医疗中心历份教学药历01tjy.pdf
文档评论(0)